About Barinthus Biotherapeutics

Barinthus Biotherapeutics develops T cell immunotherapies that guide the immune system to overcome chronic infectious diseases and autoimmunity. The company uses proprietary platform technologies to create treatments for conditions like chronic Hepatitis B, HPV related cervical lesions, and autoimmune disorders, addressing unmet medical needs where conventional approaches fall short. Job seekers join a NASDAQ listed clinical stage company with active trials and a foundation built from Oxford and NIH research. The work contributes directly to drug development advancing from discovery through late stage clinical trials, making tangible progress toward curative immunotherapy solutions for patients with limited treatment options.